<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01236807</url>
  </required_header>
  <id_info>
    <org_study_id>MR INFORM-10</org_study_id>
    <nct_id>NCT01236807</nct_id>
  </id_info>
  <brief_title>MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease</brief_title>
  <official_title>MR INFORM - a Randomized Non-inferiority Multicenter Trial Comparing MR Perfusion Imaging and Fractional Flow Reserve (FFR) to Guide Management of Patients With Stable Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if MR Perfusion Imaging is non-inferior to coronary
      angiography with measurement of Fractional Flow Reserve (FFR) in guiding management of
      patients with stable chest pain.

        -  All patients will undergo an MR Perfusion Imaging test.

        -  Further management will be guided by the result of the cardiac MRI in half of the
           patients (chosen by random).

        -  The other half will undergo coronary angiography with measurement of FFR. The result of
           this test alone will guide their further management. The result of the initial MR
           Perfusion test will not be available to the treating doctors of this group.

        -  All patients will receive optimal medical therapy (OMT)

        -  All patients will undergo follow-up to find out if they have any relevant heart related
           events.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of major adverse cardiac events (MACE)</measure>
    <time_frame>1year</time_frame>
    <description>Composite of all cause death, myocardial infarction and repeat revascularisation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Individual MACE</measure>
    <time_frame>1 year</time_frame>
    <description>individual components as defined above</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other adverse events</measure>
    <time_frame>1 year</time_frame>
    <description>need for revascularization after initial treatment within 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Course of symptoms (angina, breathlessness)</measure>
    <time_frame>1 year</time_frame>
    <description>CCS class, NYHA class</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost comparison</measure>
    <time_frame>1 year</time_frame>
    <description>Costs related to MR- and FFR-guided selection for revascularisation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in LV volumes and function</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">915</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Stable Angina</condition>
  <condition>Myocardial Ischaemia</condition>
  <arm_group>
    <arm_group_label>MR Inform</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Management guided by the result of the MR perfusion scan. Possible intervention: coronary artery revascularization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FFR Inform</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Management guided by the result of FFR measurement. Possible intervention: coronary artery revascularization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MR perfusion guidance</intervention_name>
    <description>Coronary revascularization guided by MR perfusion imaging</description>
    <arm_group_label>MR Inform</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FFR guidance</intervention_name>
    <description>Coronary revascularization guided by invasive angiography and FFR</description>
    <arm_group_label>FFR Inform</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Angina pectoris CCS class II and III and either

          -  ≥2 cardiovascular risk factors

          -  or positive exercise treadmill test

          -  Signed written informed consent

          -  age: at least 18 years

        Exclusion Criteria:

          -  contraindication to MR

          -  contraindication to adenosine infusion

          -  EF≤ 30%

          -  inability to lie supine for 60 minutes

          -  previous Coronary Artery Bypass Grafts

          -  revascularization within the previous 6 months

          -  cardiac arrhythmias (atrial fibrillation, &gt;20 ectopic beats/min)

          -  poor renal function (eGFR &lt;30ml/min)

          -  body weight &gt; 140kg or waist perimeter &gt; 95cm

          -  known allergy to contrast media
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eike Nagel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cooperative Weichteilsarkom Study Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King's College</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Hussain ST, Paul M, Plein S, McCann GP, Shah AM, Marber MS, Chiribiri A, Morton G, Redwood S, MacCarthy P, Schuster A, Ishida M, Westwood MA, Perera D, Nagel E. Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease. J Cardiovasc Magn Reson. 2012 Sep 19;14:65. doi: 10.1186/1532-429X-14-65.</citation>
    <PMID>22992411</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2010</study_first_submitted>
  <study_first_submitted_qc>November 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2010</study_first_posted>
  <last_update_submitted>December 26, 2016</last_update_submitted>
  <last_update_submitted_qc>December 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King's College London</investigator_affiliation>
    <investigator_full_name>Eike Nagel</investigator_full_name>
    <investigator_title>Global Chief Investigator</investigator_title>
  </responsible_party>
  <keyword>Adenosine</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>MR perfusion</keyword>
  <keyword>Fractional Flow Reserve, Myocardial</keyword>
  <keyword>FFR</keyword>
  <keyword>Pressure wire</keyword>
  <keyword>Coronary Disease</keyword>
  <keyword>Heart Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Arteriosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

